Loading...

quantusMM

HIGH PRECISION IMAGE DIAGNOSIS

Helps in the diagnosis of breast pathologies

PERSONALIZED CLINICAL SERVICE

OUR TEST OFFERS SAFETY AND ACCURACY WITHOUT BEING INVASIVE.

WEB SERVICES RESTFUL

Compatible HL7 FHIR
logo

¡CÓMPRALO YA!

QUANTUSMM
150€
*IVA incluído
  • Cuídate, infórmate, no arriesgues.
¡CÓMPRALO YA!
QUANTUSMM
150€
*IVA incluído
  • Cuídate, infórmate, no arriesgues.

About us

quantusMM is a non-invasive, quick and easy-to-use test for the early detection of breast pathologies, developed in collaboration with the Basque Health Service Osakidetza and the Biodonostia Institute Association.

Based on a mammography, it is capable of detecting the presence of malignant nodules or microcalcifications, thus helping to identify the risk of breast cancer.

Its technology is based on the quantitative analysis of the texture of the breast image. quantusMM classifies the images and gives them a category that determines the probability of malignancy of the analysed breast, based on sensitivity values.

quantusMM has been designed as a tool to assist clinicians, especially in mass screening of patients with risk factors, early detection of breast pathologies, and prioritisation of waiting lists.

Personalized Medicine

quantusMM is presented as an easy-to-use web application that allows specialists to upload mammography images in two perspectives (craniocaudal (CC) and oblique mid-lateral (OML)) for automatic analysis and receive reliable results within minutes.

Advantages of QuantusMM

Non invasive

Our test is non-invasive, based on a simple mammography.

Reliable

quantusMM is a test that has excellent sensitivity and specificity values, allowing the clinician to prioritise tests given the classification in which the results are presented.

Fast

You will receive the result within minutes.

HL7

COMPATIBLE HL7

quantusMM supports the HL7 FHIR protocol through its REST services.

The doctor uploads the images to the platform and, within a few minutes, quantusMM classifies the images and gives them a category which determines the probability of risk of malignancy of the analysed breast.

The test includes:
- The analysis of the breast image
- The result report in electronic format.

The test does not include:
- The doctor's consultation (ask the doctor about the possible cost)
- Other complementary tests

quantusMM has been designed with a clear focus on the general population and aims to be a tool to help clinicians, especially in mass screening of patients with risk factors, early detection of breast pathologies and prioritisation of waiting lists.

Therefore, any woman can take the test at any time.

We have at your disposal professionals who will guide you to indicate to which clinic you should go to perform your test. Contact us at the email info@transmuralbiotech.com or on the numbers +34 931190229 and +34 626667989.